{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T11:11:47Z","timestamp":1693480307470},"reference-count":14,"publisher":"VM Media Group sp. z o.o","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NCN","award":["DEC-2011\/01\/B\/NZ5\/05346"],"award-info":[{"award-number":["DEC-2011\/01\/B\/NZ5\/05346"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.pjnns.2017.12.011","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T13:07:57Z","timestamp":1515244077000},"page":"364-367","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity"],"prefix":"10.5603","volume":"52","author":[{"given":"Ewa","family":"Sobieszczuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Kubiszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Lipowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Szczudlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Szyluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Dutkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kostera-Pruszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"key":"10.1016\/j.pjnns.2017.12.011_bib0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clim.2009.03.523","article-title":"IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4","volume":"132","author":"Shandley","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0165-5728(01)00401-5","article-title":"Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis","volume":"119","author":"Stegall","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/clim.1999.4822","article-title":"Myocytes respond to both interleukin-4 and interferon-\u03b3: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis","volume":"94","author":"Stegall","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.181.2.547","article-title":"Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction","volume":"181","author":"Gu","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon \u03b3 (IFN-\u03b3) is necessary for the genesis of acetylcholine receptor \u2013 induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0100","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-\u03b3 receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0105","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jidsymp.2013.8","article-title":"The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders","volume":"16","author":"Waldmann","year":"2013","journal-title":"J Invest Derm Symp Proc"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0115","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.12659\/MSM.893458","article-title":"miR-15b is downregulated in myasthenia gravis patients and directly regulates the expression of interleukin-15 (IL-15) in experimental myasthenia gravis mice","volume":"21","author":"Shi","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/eji.1830250509","article-title":"Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats","volume":"25","author":"Zhang","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.184.2.349","article-title":"Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis","volume":"184","author":"Zhang","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/imm.12212","article-title":"Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis","volume":"142","author":"D\u00edaz-Torn\u00e9","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0135","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200318986","article-title":"Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model","volume":"112","author":"Villadsen","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1016\/j.pjnns.2017.12.011_bib0140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J Clin Immunol"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384317301020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384317301020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T12:30:44Z","timestamp":1693398644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384317301020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0028384317301020"],"URL":"https:\/\/doi.org\/10.1016\/j.pjnns.2017.12.011","relation":{},"ISSN":["0028-3843"],"issn-type":[{"value":"0028-3843","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity","name":"articletitle","label":"Article Title"},{"value":"Neurologia i Neurochirurgia Polska","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pjnns.2017.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.","name":"copyright","label":"Copyright"}]}}